{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:13:51Z","timestamp":1730783631890,"version":"3.28.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"DOI":"10.7759\/cureus.72997","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:33:23Z","timestamp":1730741603000},"source":"Crossref","is-referenced-by-count":0,"title":["From Strep Infection to a Strepitous Heart Pattern in Rheumatic Fever: A Case Report"],"prefix":"10.7759","author":[{"given":"Jomar N","family":"Machuca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.612716","article-title":"Rheumatic heart valve disease pathophysiology and underlying mechanisms","volume":"7","author":"Passos LS","year":"2020","unstructured":"Passos LS, Nunes MC, Aikawa E. Rheumatic heart valve disease pathophysiology and underlying mechanisms. Front Cardiovasc Med. 2020, 7:612716. 10.3389\/fcvm.2020.612716","journal-title":"Front Cardiovasc Med"},{"key":"ref2","article-title":"Rheumatic Heart Disease","author":"Dass C","year":"2023","unstructured":"Dass C, Kanmanthareddy A. Rheumatic Heart Disease. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref3","article-title":"Management and prevention of rheumatic heart disease","author":"Z\u00fchlke L","year":"2023","unstructured":"Z\u00fchlke L, Cupido B. Management and prevention of rheumatic heart disease. UpToDate. Pellikka PA (ed): UpToDate, Waltham; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association","volume":"142","author":"Kumar RK","year":"2020","unstructured":"Kumar RK, Antunes MJ, Beaton A, et al.. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association. Circulation. 2020, 142:e337-57. 10.1161\/CIR.0000000000000921","journal-title":"Circulation"},{"key":"ref5","unstructured":"American College of Cardiology. Diagnosis and management of rheumatic heart disease. (2020). Accessed: August 28, 2024: https:\/\/www.acc.org\/Latest-in-Cardiology\/ten-points-to-remember\/2020\/10\/30\/18\/51\/Contemporary-Diagnosis-and-Management."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeac060","article-title":"Cardiac imaging in rheumatic heart disease and future developments","volume":"3","author":"Seitler S","year":"2023","unstructured":"Seitler S, Zuhair M, Shamsi A, et al.. Cardiac imaging in rheumatic heart disease and future developments. Eur Heart J Open. 2023, 3:oeac060. 10.1093\/ehjopen\/oeac060","journal-title":"Eur Heart J Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2022.10.009","article-title":"Recommendations for the use of echocardiography in the evaluation of rheumatic heart disease: a report from the American Society of Echocardiography","volume":"36","author":"Pandian NG","year":"2023","unstructured":"Pandian NG, Kim JK, Arias-Godinez JA, et al.. Recommendations for the use of echocardiography in the evaluation of rheumatic heart disease: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2023, 36:3-28. 10.1016\/j.echo.2022.10.009","journal-title":"J Am Soc Echocardiogr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.09.050","article-title":"Rheumatic heart disease: JACC focus seminar 2\/4","volume":"81","author":"Dougherty S","year":"2023","unstructured":"Dougherty S, Okello E, Mwangi J, Kumar RK. Rheumatic heart disease: JACC focus seminar 2\/4. J Am Coll Cardiol. 2023, 81:81-94. 10.1016\/j.jacc.2022.09.050","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.shj.2023.100219","article-title":"Rheumatic heart disease in the developing world","volume":"7","author":"Simpson MT","year":"2023","unstructured":"Simpson MT, Kachel M, Neely RC, et al.. Rheumatic heart disease in the developing world. Struct Heart. 2023, 7:100219. 10.1016\/j.shj.2023.100219","journal-title":"Struct Heart"},{"key":"ref10","article-title":"Rheumatic mitral stenosis: clinical manifestations and diagnosis","author":"Otto CM","year":"2022","unstructured":"Otto CM. Rheumatic mitral stenosis: clinical manifestations and diagnosis. UpToDate. Meyer TE (ed): UpToDate, Waltham; 2022."},{"key":"ref11","article-title":"Mitral valve disease: clinical features focusing on auscultatory findings including auscultation of mitral valve prolapse","volume":"16","author":"Chatterjee D","year":"2018","unstructured":"Chatterjee D. Mitral valve disease: clinical features focusing on auscultatory findings including auscultation of mitral valve prolapse. Eur Soc Cardiol. 2018, 16:1-10.","journal-title":"Eur Soc Cardiol"},{"key":"ref12","article-title":"Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990-2017: a population-based study","volume":"7","author":"Ordunez P","year":"2019","unstructured":"Ordunez P, Martinez R, Soliz P, Giraldo G, Mujica OJ, Nordet. Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990-2017: a population-based study. Lancet. 2019, 7:1388-1397.","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-003-0077-1","article-title":"Vena contracta width measurement: theoretic basis and usefulness in the assessment of valvular regurgitation severity","volume":"5","author":"Qu\u00e9r\u00e9 JP","year":"2003","unstructured":"Qu\u00e9r\u00e9 JP, Tribouilloy C, Enriquez-Sarano M. Vena contracta width measurement: theoretic basis and usefulness in the assessment of valvular regurgitation severity. Curr Cardiol Rep. 2003, 5:110-5. 10.1007\/s11886-003-0077-1","journal-title":"Curr Cardiol Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00962-23","article-title":"Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study","volume":"67","author":"Kado J","year":"2023","unstructured":"Kado J, Salman S, Hla TK, et al.. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study. Antimicrob Agents Chemother. 2023, 67:e0096223. 10.1128\/aac.00962-23","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102074","article-title":"Secondary antibiotic prophylaxis for latent rheumatic heart disease","volume":"386","author":"Beaton A","year":"2022","unstructured":"Beaton A, Okello E, Rwebembera J, et al.. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med. 2022, 386:230-40. 10.1056\/NEJMoa2102074","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2022.034","article-title":"Therapeutics for rheumatic fever and rheumatic heart disease","volume":"45","author":"Ralph AP","year":"2022","unstructured":"Ralph AP, Currie BJ. Therapeutics for rheumatic fever and rheumatic heart disease. Aust Prescr. 2022, 45:104-12. 10.18773\/austprescr.2022.034","journal-title":"Aust Prescr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021, 143:e72-e227. 10.1161\/CIR.0000000000000923","journal-title":"Circulation"},{"key":"ref18","article-title":"Chronic primary mitral regurgitation: general management","author":"Nkomo VT","year":"2023","unstructured":"Nkomo VT. Chronic primary mitral regurgitation: general management. UpToDate. Otto CM (ed): UpToDate, Waltham; 2023."},{"key":"ref19","article-title":"Limits to surgery in mitral valve disease","volume":"8","author":"Al-Attar W","year":"2010","unstructured":"Al-Attar W. Limits to surgery in mitral valve disease. Eur Soc Cardiol. 2010, 8:1-5.","journal-title":"Eur Soc Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/hrs guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Joglar JA","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al.. 2023 ACC\/AHA\/ACCP\/hrs guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024, 149:e1-e156. 10.1161\/CIR.0000000000001193","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.702780","article-title":"Antithrombotic treatment after surgical and transcatheter heart valve repair and replacement","volume":"8","author":"Verstraete A","year":"2021","unstructured":"Verstraete A, Herregods MC, Verbrugghe P, et al.. Antithrombotic treatment after surgical and transcatheter heart valve repair and replacement. Front Cardiovasc Med. 2021, 8:702780. 10.3389\/fcvm.2021.702780","journal-title":"Front Cardiovasc Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022, 145:e895-e1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/288252-from-strep-infection-to-a-strepitous-heart-pattern-in-rheumatic-fever-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:33:25Z","timestamp":1730741605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/288252-from-strep-infection-to-a-strepitous-heart-pattern-in-rheumatic-fever-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.72997","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}